Breast neoplasms Clinical Trials
Conditions / Breast neoplasms
Delta Trials tracks 842 clinical trials for Breast neoplasms in its publicly accessible dataset. Among the listed trials, 117 open for participant enrollment and 450 trials have reached completion. This research is carried out at 2,845 clinical sites around the world. An additional 275 trials have active registrations outside the recruiting and completed categories. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
842
Total Trials
117
Recruiting
450
Completed
275
Other Active
0
Terminated since 2020
2845
Study Locations
Browse by location (2845 total)
- Seoul, South Korea 65 trialsAll trials in Seoul, South Korea
- Houston, United States 59 trialsAll trials in Houston, United States
- Madrid, Spain 59 trialsAll trials in Madrid, Spain
- Barcelona, Spain 56 trialsAll trials in Barcelona, Spain
- Beijing, China 53 trialsAll trials in Beijing, China
- Boston, United States 52 trialsAll trials in Boston, United States
- New York, United States 52 trialsAll trials in New York, United States
- Los Angeles, United States 52 trialsAll trials in Los Angeles, United States
- Nashville, United States 51 trialsAll trials in Nashville, United States
- Toronto, Canada 46 trialsAll trials in Toronto, Canada
- Milan, Italy 45 trialsAll trials in Milan, Italy
- St. Louis, United States 45 trialsAll trials in St. Louis, United States
- St. Louis, United States 45 trialsAll trials in St. Louis, United States
- London, United Kingdom 44 trialsAll trials in London, United Kingdom
- Dallas, United States 44 trialsAll trials in Dallas, United States
- Paris, France 44 trialsAll trials in Paris, France
- Paris, France 44 trialsAll trials in Paris, France
- Guangzhou, China 40 trialsAll trials in Guangzhou, China
- Taipei, Taiwan 38 trialsAll trials in Taipei, Taiwan
- Taipei, Taiwan 38 trialsAll trials in Taipei, Taiwan